Stem Cells – Healthcare of the Future
Investors
Invest in Future Medicine:
Parkinson Disease
PD is a movement disorder with three cardinal signs: tremor, rigidity and bradykinesia. Parkinson’s disease is the second most common age-related neurodegenerative disorder after Alz-heimer’s disease. An estimated 7 to 10 million people worldwide have Parkinson’s disease.
Future: Treatment of Parkinson disease with mesenchymal stem cells and their secretome.
Be part of this new approach to cure Parkinson Disease with autologous stem cell derived treatments.
Invest in Future Medicine:
Alzheimer’s Disease
Alzheimer’s disease is an irreversible degeneration of the brain that causes disruptions in memory, cognition, personality, and other functions that eventually lead to death from complete brain failure. There were an estimated 46.8 million people worldwide living with dementia in 2015 and this number is believed to be close to 50 million people in 2017.
Future: Treatment of Alzheimer’s disease with mesenchymal stem cells and their secretome.
Be part of this new approach to cure Alzheimer‘s Disease with autologous stem cell derived treatments.